ATE334655T1 - Amoxicillin und clavulanat enthaltende pharmazeutische formulierung - Google Patents

Amoxicillin und clavulanat enthaltende pharmazeutische formulierung

Info

Publication number
ATE334655T1
ATE334655T1 AT00202882T AT00202882T ATE334655T1 AT E334655 T1 ATE334655 T1 AT E334655T1 AT 00202882 T AT00202882 T AT 00202882T AT 00202882 T AT00202882 T AT 00202882T AT E334655 T1 ATE334655 T1 AT E334655T1
Authority
AT
Austria
Prior art keywords
clavulanate
pharmaceutical formulation
formulation containing
flavour
containing amoxicillin
Prior art date
Application number
AT00202882T
Other languages
English (en)
Inventor
Nathalie Barges
Jacky Andre Gustave Mention
Original Assignee
Glaxosmithkline Lab Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9919840.0A external-priority patent/GB9919840D0/en
Priority claimed from GBGB9920150.1A external-priority patent/GB9920150D0/en
Priority claimed from GB0019084A external-priority patent/GB0019084D0/en
Application filed by Glaxosmithkline Lab Sas filed Critical Glaxosmithkline Lab Sas
Application granted granted Critical
Publication of ATE334655T1 publication Critical patent/ATE334655T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00202882T 1999-08-20 2000-08-17 Amoxicillin und clavulanat enthaltende pharmazeutische formulierung ATE334655T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9919840.0A GB9919840D0 (en) 1999-08-20 1999-08-20 Pharmaceutical formulation
GBGB9920150.1A GB9920150D0 (en) 1999-08-25 1999-08-25 Pharmaceuticals formulation
GB0019084A GB0019084D0 (en) 2000-08-03 2000-08-03 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ATE334655T1 true ATE334655T1 (de) 2006-08-15

Family

ID=27255829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00202882T ATE334655T1 (de) 1999-08-20 2000-08-17 Amoxicillin und clavulanat enthaltende pharmazeutische formulierung

Country Status (9)

Country Link
US (1) US6977086B1 (de)
EP (1) EP1078627B1 (de)
AT (1) ATE334655T1 (de)
AU (1) AU6571400A (de)
DE (1) DE60029698T2 (de)
DK (1) DK1078627T3 (de)
ES (1) ES2269063T3 (de)
PT (1) PT1078627E (de)
WO (1) WO2001013883A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
BRPI0411524A (pt) * 2003-06-16 2006-08-01 Glaxo Group Ltd formulação farmacêutica de amoxicilina e clavulanato, uso de carboximetilcelulose de sódio, e, método de tratar infecção bacteriana em pacientes pediátricos
GB0313913D0 (en) * 2003-06-16 2003-07-23 Beecham Pharm Pte Ltd New use
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CA2661576A1 (en) * 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
CN101406450B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方阿莫西林油混悬注射液制备工艺
WO2010132662A1 (en) * 2009-05-13 2010-11-18 Relypsa, Inc. Powder formulations of potassium-binding active agents
KR101486999B1 (ko) * 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
KR101178217B1 (ko) 2009-10-28 2012-09-07 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
TWI463998B (zh) * 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
CN114668724B (zh) * 2020-12-24 2023-08-22 鲁南制药集团股份有限公司 一种阿莫西林克拉维酸钾干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114929A (en) * 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
EA002595B1 (ru) 1997-02-14 2002-06-27 Смитклайн Бичем Лаборатуар Фармасетик Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation

Also Published As

Publication number Publication date
EP1078627A1 (de) 2001-02-28
WO2001013883A1 (en) 2001-03-01
DK1078627T3 (da) 2006-11-13
AU6571400A (en) 2001-03-19
ES2269063T3 (es) 2007-04-01
US6977086B1 (en) 2005-12-20
DE60029698D1 (de) 2006-09-14
EP1078627B1 (de) 2006-08-02
DE60029698T2 (de) 2007-08-02
PT1078627E (pt) 2006-10-31

Similar Documents

Publication Publication Date Title
ATE334655T1 (de) Amoxicillin und clavulanat enthaltende pharmazeutische formulierung
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
PT1087960E (pt) Análogos macrocíclicos e métodos de sua utilização e preparação
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
DE69423966D1 (de) Neue strukturelle vitamin d derivate
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
ATE325093T1 (de) ß2-OXO-1-PYRROLIDINDERIVATE UND IHRE PHARMAZEUTISCHE VERWENDUNGß
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
MA27107A1 (fr) Formulations aerosoles pour l'administration pulmonaire de medicaments visant a produire un effet systemique.
EP1093812A3 (de) Amoxycillin und Clavulanat enthaltende pharmazeutische Zusammensetzung
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
ATE301986T1 (de) Kosmetische stiftzubereitung
ATE409474T1 (de) Tryptamin-derivative und analoge verbindungen, und pharmazeutische formulationen daraus
EE200100596A (et) Ülipuhas (1R,2S,4R)-(-)-2-[(2'-{N,N-dimetüülamino}etoksü)]-2-[fenüül]-1,7,7-tri[metüül]bitsüklo[2.2.1 ]heptaan ja selle farmatseutiliselt vastuvõetavad happeliitsoolad ning nimetatud ühendite, samutiravimite, mis sisaldavad üks või enam nimetatud üh
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HK1045102A1 (zh) 藥物配方
GEP20043377B (en) Pharmaceutical Complex
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
WO2001060326A3 (fr) Composition cosmetique ou pharmaceutique contenant une lactone sesquiterpenique
SE9902938D0 (sv) Pharmaceutical compositions
DE69306263D1 (de) Neue pharmazeutische formulierung enthaltend spiramycine
ATE139703T1 (de) Aureobasidin enthaltendes arzneimittel
IT1257000B (it) Derivati dell'eserolina ad attivita` anticolinesterasica, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1078627

Country of ref document: EP

REN Ceased due to non-payment of the annual fee